Abstract
The objective of our study was to evaluate the diagnostic performance of dual-source dual-energy CT (DECT) in the detection of endoleaks after thoracic endovascular aortic repair for thoracic aortic aneurysm and to investigate if a double-phase (arterial and dual-energy late delayed phase) or a single-phase (dual-energy late delayed phase) acquisition can replace the standard triphasic protocol. All DECT examinations performed for evaluation after thoracic endovascular aortic repair during a 30-month period were retrospectively reviewed. An initial single-source unenhanced acquisition was followed by a single-source arterial phase acquisition and a dual-energy 300-second late delayed phase acquisition. "Virtual noncontrast images" were generated from the dual-energy acquisition. Two independent and blinded radiologists evaluated the cases during three reading sessions: session A (triphasic protocol: standard unenhanced, arterial phase, and late delayed phase), session B (virtual noncontrast and late delayed phase), and session C (virtual noncontrast, arterial phase, and late delayed phase). The diagnostic accuracies of sessions B and C were calculated using session A as the reference standard. Contrast-to-noise ratios and effective radiation doses were calculated. Forty-eight patients (mean age, 66 years; age range, 19-84 years) underwent 74 triple-phase CT examinations. The single-phase studies (session B) were characterized by 85.7% sensitivity, 100% specificity, 100% negative predictive value (NPV), and 94.6% positive predictive value (PPV). The dual-phase study (session C) revealed 100% sensitivity, 100% specificity, 100% NPV, and 100% PPV. The use of the dual-phase protocol and single-phase protocol resulted in a radiation exposure reduction of 19.5% and 64.1%, respectively. Virtual noncontrast and late delayed phase images reconstructed from a single DECT acquisition can replace the standard triphasic protocol in follow-up examinations after thoracic endovascular aortic repair, thereby providing a significant dose reduction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.